Source: International Congress 2016 – Novel avenues in the treatment of COPD II
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Carlos Andrès Celis Preciado (Bogota, Cundinamarca, Colombia), Carlos Andrés Celis Preciado, Horacio Giraldo, Dario Londoño, Ingrid Rodriguez. Glaucoma risk due to antimuscarinics, not a class effect: A systematic review. Eur Respir J 2016; 48: Suppl. 60, 4069

Member's Comments

No comment yet.

Related content which might interest you: Concurrent use of long-acting bronchodilators in COPD and the risk of adverse cardiovascular events: A population-based study Source: International Congress 2016 – Pharmacological treatment of COPD: focus on LABA/LAMA combinations Year: 2016 Long-acting bronchodilator initiation in COPD and cardio-pulmonary risks: A population-based comparative effectiveness study Source: International Congress 2016 – Novel avenues in the treatment of COPD II Year: 2016 Analyzing the pathway to triple therapy in COPD patients: A retrospective database analysis Source: International Congress 2014 – New clinical evidence for asthma and COPD treatments Year: 2014 The patient’s role in the choice of new inhaler devices and dosing regimens for asthma and COPD: A preference study Source: International Congress 2016 – Kaleidoscope of respiratory nursing Year: 2016 Educational inhaler technique interventions in asthma & COPD patients: A systematic review Source: International Congress 2016 – Management of asthma and COPD in primary care Year: 2016 QVA149 provides significant symptomatic benefit to COPD patients as measured by a new symptom e-diary: The SHINE study Source: International Congress 2015 – New data on established treatments for COPD Year: 2015 Patients’ opinion for their inhalation device. An assessment of convenience and use Source: Annual Congress 2013 –Treatment and management of asthma in primary care Year: 2013 Systematic analysis of self-reported comorbidities in the COSYCONET COPD cohort study by stepwise evaluation of medication Source: International Congress 2016 – Comorbidities and exacerbations in COPD Year: 2016 Real-life study on the aPpropriaTeness of treatment in moderate COPD patients (OPTIMO) Source: Annual Congress 2013 –COPD drugs: new findings Year: 2013 Effect of QVA149 on lung function in the subgroup of patients with a history of exacerbations in the previous year and baseline ICS use from the SHINE study Source: International Congress 2014 – Asthma and COPD devices and treatments Year: 2014 Top-10 comorbidities of symptomatic patients with moderate COPD in the clinical setting of the CRYSTAL study Source: International Congress 2016 – Features and impact of comorbidities in COPD Year: 2016 Inhaled treatment of COPD: A delphi consensus statement Source: International Congress 2016 – Pharmacological management of COPD Year: 2016 Differences in adherence to common inhaled medications in COPD Source: Annual Congress 2013 –COPD drugs: new findings Year: 2013 Vitamin D for the management of asthma: Cochrane systematic review and meta-analysis Source: International Congress 2016 – Asthma management Year: 2016 GLISTEN Study subanalysis: Glycopyrronium differentially improves lung function, health status and rescue medication use when added to salmeterol/fluticasone in COPD severity groups Source: International Congress 2015 – New data on established treatments for asthma, COPD and bronchiectasis Year: 2015 Influence of patient baseline characteristics and concomitant medication on outcomes in long-term trials of COPD: Analysis of the UPLIFT® trial Source: Annual Congress 2013 –Clinical trials of LAMAs, LABAs, MABAs and theophylline for asthma and COPD Year: 2013 Long-acting bronchodilators (LABDs) and major adverse cardiac events (MACE) in patients with COPD: A pooled analysis of 12 randomised trials Source: International Congress 2016 – Novel avenues in the treatment of COPD I Year: 2016 Real-world prescribing patterns among newly diagnosed COPD patients receiving ICS: An analysis of UK patient dataset Source: International Congress 2014 – New clinical evidence for asthma and COPD treatments Year: 2014 Contraindications and precautions with inhalation therapy in COPD. Awareness or unawareness, a questionaire Source: Annual Congress 2013 –Asthma and COPD drugs: efficacy, safety and pharmacoeconomics Year: 2013 Anti-depressants in severe and brittle asthma patients on long term corticosteroids: An observational study Source: Annual Congress 2013 –Asthma at the bedside Year: 2013